Related references
Note: Only part of the references are listed.Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
Shuai Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Nasim Mavaddat et al.
JAMA ONCOLOGY (2022)
Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil
Gabriela E. S. Felix et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
Rodrigo Santa Cruz Guindalini et al.
SCIENTIFIC REPORTS (2022)
Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
Yukihide Momozawa et al.
JAMA ONCOLOGY (2022)
Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer
Gabriel Bandeira et al.
BREAST CANCER (2021)
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis
Renata Lazari Sandoval et al.
PLOS ONE (2021)
Integration among national health information systems in Brazil: the case of e-SUS Primary Care
Giliate Cardoso Coelho Neto et al.
REVISTA DE SAUDE PUBLICA (2021)
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)
Jennifer D. Brooks et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients
Renan Gomes et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population
Simone da Costa e Silva Carvalho et al.
BMC MEDICAL GENOMICS (2020)
Systematic misclassification of missense variants in BRCA1 and BRCA2 coldspots
Jennifer N. Dines et al.
GENETICS IN MEDICINE (2020)
Ethnic disparities in the frequency of cancer reported in family histories
Heather Maves et al.
JOURNAL OF GENETIC COUNSELING (2020)
NCCN: Continuing Education
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets
Can-Bin Fang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
Maria Isabel Achatz et al.
JCO GLOBAL ONCOLOGY (2020)
Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan
Fei-Hung Hung et al.
SCIENTIFIC REPORTS (2019)
Predicting Splicing from Primary Sequence with Deep Learning
Kishore Jaganathan et al.
CELL (2019)
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort
J. J. Bakhuizen et al.
FAMILIAL CANCER (2019)
Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers
Hideko Yamauchi et al.
BREAST CANCER (2018)
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Timothy R. Rebbeck et al.
HUMAN MUTATION (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
Edenir Inez Palmero et al.
SCIENTIFIC REPORTS (2018)
Accurate classification of BRCA1 variants with saturation genome editing
Gregory M. Findlay et al.
NATURE (2018)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Baarbara Alemar et al.
PLOS ONE (2017)
Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology
Ana Ligia Buzolin et al.
HUMAN GENOMICS (2017)
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
Jessica A. Cintolo-Gonzalez et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Genetic testing in a cohort of young patients with HER2-amplified breast cancer
D. M. Eccles et al.
ANNALS OF ONCOLOGY (2016)
Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation
Kelvin C. Andrade et al.
GENETICS AND MOLECULAR BIOLOGY (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
HGVS Recommendations for the Description of Sequence Variants: 2016 Update
Johan T. den Dunnen et al.
HUMAN MUTATION (2016)
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015 Featured Updates to the NCCN Guidelines
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
The Inherited p53 Mutation in the Brazilian Population
Maria Isabel Achatz et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective
Julie Dutil et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Patterns and functional implications of rare germline variants across 12 cancer types
Charles Lu et al.
NATURE COMMUNICATIONS (2015)
Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil
Patricia Ashton-Prolla et al.
JOURNAL OF COMMUNITY GENETICS (2015)
Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
Felipe C. Silva et al.
BMC MEDICAL GENETICS (2014)
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
A. J. Lee et al.
BRITISH JOURNAL OF CANCER (2014)
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Genomic HEXploring allows landscaping of novel potential splicing regulatory elements
Steffen Erkelenz et al.
NUCLEIC ACIDS RESEARCH (2014)
Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
Juliana Giacomazzi et al.
PLOS ONE (2014)
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families
Nathalia M. Cury et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2014)
Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers
Jessica E. Cott Chubiz et al.
CANCER (2013)
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer
Haeyoung Kim et al.
JOURNAL OF BREAST CANCER (2013)
Hereditary breast and ovarian cancer susceptibility genes
Hiroshi Kobayashi et al.
ONCOLOGY REPORTS (2013)
Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil
Dirce Maria Carraro et al.
PLOS ONE (2013)
Assessment of SLX4 Mutations in Hereditary Breast Cancers
Sohela Shah et al.
PLOS ONE (2013)
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members
Mads Thomassen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer
Anne-Renee Hartman et al.
CANCER (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations
Nancy Hamel et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Quantitative evaluation of all hexamers as exonic splicing elements
Shengdong Ke et al.
GENOME RESEARCH (2011)
Practical Tools to Implement Massive Parallel Pyrosequencing of PCR Products in Next Generation Molecular Diagnostics
Kim De Leeneer et al.
PLOS ONE (2011)
Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study
Noralane M. Lindor et al.
FAMILIAL CANCER (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal
Ana Peixoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry
Allison W. Kurian et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Selecting a BRCA risk assessment model for use in a familial cancer clinic
Seema M. Panchal et al.
BMC MEDICAL GENETICS (2008)
Detection of R337H a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
Edenir Inez Palmero et al.
CANCER LETTERS (2008)
Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer
E. Thirthagiri et al.
BREAST CANCER RESEARCH (2008)
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
Magda C. B. Gomes et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
novoSNP, a novel computational tool for sequence variation discovery
S Weckx et al.
GENOME RESEARCH (2005)
BRCA1 mutations in Brazilian patients
JJ Lourenço et al.
GENETICS AND MOLECULAR BIOLOGY (2004)
The ancestry of Brazilian mtDNA lineages
J Alves-Silva et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
